Lifevantage Current Ratio 2010-2022 | LFVN
Lifevantage current ratio from 2010 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Lifevantage Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2022-12-31 |
$0.04B |
$0.02B |
1.90 |
| 2022-09-30 |
$0.04B |
$0.02B |
1.89 |
| 2022-06-30 |
$0.05B |
$0.03B |
1.83 |
| 2022-03-31 |
$0.05B |
$0.02B |
1.91 |
| 2021-12-31 |
$0.04B |
$0.02B |
1.93 |
| 2021-09-30 |
$0.05B |
$0.02B |
2.02 |
| 2021-06-30 |
$0.05B |
$0.03B |
1.91 |
| 2021-03-31 |
$0.04B |
$0.02B |
1.96 |
| 2020-12-31 |
$0.04B |
$0.02B |
1.89 |
| 2020-09-30 |
$0.04B |
$0.02B |
1.86 |
| 2020-06-30 |
$0.04B |
$0.03B |
1.75 |
| 2020-03-31 |
$0.04B |
$0.02B |
1.62 |
| 2019-12-31 |
$0.04B |
$0.03B |
1.49 |
| 2019-09-30 |
$0.04B |
$0.03B |
1.67 |
| 2019-06-30 |
$0.04B |
$0.03B |
1.65 |
| 2019-03-31 |
$0.04B |
$0.03B |
1.55 |
| 2018-12-31 |
$0.04B |
$0.03B |
1.52 |
| 2018-09-30 |
$0.04B |
$0.02B |
1.72 |
| 2018-06-30 |
$0.04B |
$0.02B |
1.64 |
| 2018-03-31 |
$0.04B |
$0.03B |
1.53 |
| 2017-12-31 |
$0.04B |
$0.02B |
1.55 |
| 2017-09-30 |
$0.03B |
$0.02B |
1.54 |
| 2017-06-30 |
$0.04B |
$0.02B |
1.52 |
| 2017-03-31 |
$0.04B |
$0.03B |
1.52 |
| 2016-12-31 |
$0.04B |
$0.02B |
1.56 |
| 2016-09-30 |
$0.04B |
$0.03B |
1.48 |
| 2016-06-30 |
$0.04B |
$0.03B |
1.41 |
| 2016-03-31 |
$0.04B |
$0.03B |
1.41 |
| 2015-12-31 |
$0.04B |
$0.04B |
1.05 |
| 2015-09-30 |
$0.03B |
$0.03B |
1.10 |
| 2015-06-30 |
$0.03B |
$0.03B |
1.18 |
| 2015-03-31 |
$0.04B |
$0.03B |
1.41 |
| 2014-12-31 |
$0.04B |
$0.02B |
1.79 |
| 2014-09-30 |
$0.04B |
$0.02B |
1.87 |
| 2014-06-30 |
$0.04B |
$0.02B |
1.76 |
| 2014-03-31 |
$0.06B |
$0.03B |
2.22 |
| 2013-12-31 |
$0.05B |
$0.02B |
2.41 |
| 2013-09-30 |
$0.05B |
$0.02B |
2.44 |
| 2013-06-30 |
$0.05B |
$0.02B |
2.23 |
| 2013-03-31 |
$0.04B |
$0.02B |
2.36 |
| 2012-12-31 |
$0.04B |
$0.02B |
2.37 |
| 2012-09-30 |
$0.04B |
$0.02B |
2.69 |
| 2012-06-30 |
$0.04B |
$0.02B |
2.42 |
| 2012-03-31 |
$0.03B |
$0.01B |
2.68 |
| 2011-12-31 |
$0.02B |
$0.02B |
1.36 |
| 2011-09-30 |
$0.02B |
$0.01B |
1.04 |
| 2011-06-30 |
$0.01B |
$0.01B |
0.77 |
| 2011-03-31 |
$0.01B |
$0.01B |
0.57 |
| 2010-12-31 |
$0.01B |
$0.01B |
0.85 |
| 2010-09-30 |
$0.00B |
$0.00B |
1.01 |
| 2010-06-30 |
$0.00B |
$0.01B |
0.59 |
| 2010-03-31 |
$0.00B |
$0.01B |
0.61 |
| 2009-12-31 |
$0.00B |
$0.01B |
0.33 |
| 2009-09-30 |
$0.00B |
$0.01B |
0.37 |
| 2009-06-30 |
$0.00B |
$0.00B |
0.80 |
| 2009-03-31 |
$0.00B |
$0.00B |
1.17 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.045B |
$0.206B |
|
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
|
